Beard M E, Heaton D C, Hamer J W, Watson J, Abbott G D, Bremner J, Snape L
N Z Med J. 1981 Jul 22;94(688):41-3.
Thirty-two Hickman central venous catheters were placed in patients suffering mainly from blood disorders. The catheters remained in situ for an average of 64 days. In 20 patients the catheters were removed either because they were no longer needed (14) or at death (6). In five patients they are still in position. Complications in seven patients led to the catheter being removed and these included four patients with catheter related sepsis. The use of these catheters allows safe long-term access to the venous circulation even in the neutropenic, immunosuppressed patient.
32根希克曼中心静脉导管被放置在主要患有血液疾病的患者体内。这些导管平均留置64天。在20名患者中,导管被拔除,其中14例是因为不再需要,6例是在患者死亡时拔除。5名患者的导管仍在位。7名患者出现并发症导致导管被拔除,其中包括4例与导管相关的败血症。即使对于中性粒细胞减少、免疫抑制的患者,使用这些导管也能安全地长期进入静脉循环。